Immune checkpoint inhibitors: A narrative review of considerations for the anaesthesiologist Review


Authors: Lewis, A. L.; Chaft, J.; Girotra, M.; Fischer, G. W.
Review Title: Immune checkpoint inhibitors: A narrative review of considerations for the anaesthesiologist
Abstract: Immunotherapy has revolutionised the treatment of oncologic malignancies. Immune checkpoint inhibitors represent a new class of immunotherapy drugs. Although these drugs show promise, they are associated with immune-related adverse reactions. An increasing number of patients who undergo surgery will have had treatment with immune checkpoint inhibitors. In this narrative review article, we discuss their mechanism of action, therapeutic effects, pertinent toxicities, and address specific perioperative considerations for patients treated with immune checkpoint inhibitors. © 2019 British Journal of Anaesthesia
Keywords: unclassified drug; review; drug efficacy; drug safety; nonhuman; preoperative evaluation; cancer immunotherapy; immune system; lung toxicity; gastrointestinal toxicity; immunotherapy; drug mechanism; cardiotoxicity; complications; tumor immunity; endocrine disease; molecularly targeted therapy; cancer immunology; adverse events; side effects; immune checkpoint inhibitor; cancer; human; priority journal; perioperative management; anesthesiologist; anaesthesia; immune checkpoint inhibitors; malignant neoplasm; immunological antineoplastic agent
Journal Title: British Journal of Anaesthesia
Volume: 124
Issue: 3
ISSN: 0007-0912
Publisher: Oxford University Press  
Date Published: 2020-03-01
Start Page: 251
End Page: 260
Language: English
DOI: 10.1016/j.bja.2019.11.034
PUBMED: 32007241
PROVIDER: scopus
PMCID: PMC7890563
DOI/URL:
Notes: Review -- Export Date: 2 March 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Girotra
    22 Girotra
  2. Jamie Erin Chaft
    289 Chaft
  3. Alexandra Leah Lewis
    8 Lewis
  4. Gregory Walter Fischer
    40 Fischer